p>Applicants with experience in any of the below indications will be considered: • Monitoring as a CRA or working as a study coordinator or clinician • Solid Tumor Breast/Ovarian/Prostate/Colorectal/Bladder/Lung/Kidney/Pancreatic Cancer • Small Cell Lung Cancer • Graft vs Host Disease • Glioblastoma • Melanoma • Leukemia • Lymphoma • Mesothelioma.
Named a Top Workplace in 2024 by The Cincinnati Enquirer Recognized by Forbes as one of Americas Most Successful Midsize Companies in 2021, 2022, 2023 and 2024 Continually recognized with CRO Leadership Awards from Life Science Leader magazine based on expertise, quality, capabilities, reliability, and compatibility.